Effectiveness of a Digital Behavioral Intervention Program for Overweight and Obese Patients
Study on the Construction and Effectiveness of a Digital Behavioral Intervention Program for Overweight and Obese Patients Prior to Assisted Reproductive Technology(ART)Treatment
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
This study applied digital technology to a comprehensive lifestyle intervention strategy to design a digital behavioural intervention programme suitable for weight reduction in overweight obese infertile patients in China, and assessed its intervention effect through a randomised controlled trial.The main questions it aims to answer are: 1\) Design and implement a digital behavioural weight loss intervention programme; 2) Evaluate the impact of digital behavioural interventions on weight loss outcomes and health outcomes. Participants will be randomly assigned to a control group and an intervention group. The control group will receive only routine health education and the intervention group will receive an 8-week digital behavioural intervention. At the end of the intervention, the follow-up period will be one year for reproductive outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2025
CompletedFirst Posted
Study publicly available on registry
July 1, 2025
CompletedStudy Start
First participant enrolled
July 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 20, 2027
July 1, 2025
June 1, 2025
1.1 years
June 9, 2025
June 21, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Weight change
From enrollment to the end of treatment at 8 weeks
Number of oocytes retrieved
up to 16weeks
Number of embryos available for transfer
up to 17 weeks
Secondary Outcomes (4)
Percentage of weight loss
From enrollment to the end of treatment at 8 weeks
Body fat content and distribution
From enrollment to the end of treatment at 8 weeks
live birth rate
2 years
Pregnancy rate
up to 1 year
Study Arms (2)
digital behavioral intervention
EXPERIMENTALA comprehensive intervention program that combines digital technologies,Including interventions for diet, exercise, mood, sleep, etc.
Regular Education Group
NO INTERVENTIONPhysicians provided only their standard verbal counseling during clinic visits, without any additional interventions.
Interventions
The intervention team provides lifestyle guidance to the subjects according to the behavioural intervention programme, and the subjects record information on diet, exercise and weight on the platform on a daily basis. Subjects are required to learn relevant health education knowledge on the platform by themselves, and they can also exchange experience in the group and receive motivational counselling from the instructors.
Eligibility Criteria
You may qualify if:
- Fulfilling the World Health Organization diagnostic criteria for infertility, defined as failure to achieve or sustain a clinical pregnancy after ≥1 year of regular unprotected sexual intercourse among couples of reproductive age;
- patients aged 20-40 years seeking assisted reproductive technology (ART) treatment;
- Body mass index (BMI) \>=24 kg/m²;
- Willingness to undergo randomization;
- Absence of significant comorbidities (e.g., uncontrolled hypertension, diabetes mellitus, malignancies);
- Commitment to participate in and complete the intervention protocol.
You may not qualify if:
- History of major systemic diseases (e.g., cardiovascular disorders, chronic respiratory diseases) or psychiatric disorders (e.g., schizophrenia, major depressive disorder);
- Current or prior participation in other clinical trials within the past 3 months;
- Medical contraindications to physical exercise (e.g., severe osteoarthritis, uncontrolled arrhythmias);
- Previous weight-loss interventions, including pharmacological therapy (e.g., orlistat, liraglutide) or bariatric surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 9, 2025
First Posted
July 1, 2025
Study Start
July 10, 2025
Primary Completion (Estimated)
August 20, 2026
Study Completion (Estimated)
August 20, 2027
Last Updated
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share